First known person-to-person transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the USA

The Lancet

Volumn 395, Issue 10230, 2020, Pages 1137-1144

  Ghinai, Isaac ^a,d   McPherson, Tristan D ^a,e   Hunter, Jennifer C ^b   Kirking, Hannah L ^c   Christiansen, Demian ^f   Joshi, Kiran ^f   Rubin, Rachel ^f   Morales Estrada, Shirley ^f   Black, Stephanie R ^e   Pacilli, Massimo ^e   Fricchione, Marielle J ^e   Chugh, Rashmi K ^g   Walblay, Kelly A ^e   Ahmed, N Seema ^h   Stoecker, William C ^h   Hasan, Nausheen F ⁱ   Burdsall, Deborah P ^d   Reese, Heather E ^a,c   Wallace, Megan ^a,c   Wang, Chen ^j,k   Moeller, Darcie ^j,k   Korpics, Jacqueline ^j,k   Novosad, Shannon A ^b   Benowitz, Isaac ^b   Jacobs, Max W ^c,l   Dasari, Vishal S ^b,m   Patel, Megan T ^d   Kauerauf, Judy ^d   Charles, E Matt ^d   Ezike, Ngozi O ^d   Chu, Victoria ^a,c   Midgley, Claire M ^c   Rolfes, Melissa A ^c   Gerber, Susan I ^c   Lu, Xiaoyan ^c   Lindstrom, Stephen ^c   Verani, Jennifer R ^c   Layden, Jennifer E ^e   more..

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^c NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^d ILLINOIS DEPARTMENT OF PUBLIC HEALTH   (United States)

^e CHICAGO DEPARTMENT OF PUBLIC HEALTH   (United States)

^f Metro Infectious Disease Consultants ^*  (United States)

^g DuPage County Health Department   (United States)

^h Metro Infectious Diseases Consultants   (United States)

ⁱ Premier Primary Care Physicians   (United States)

^j Hospital of Cook County   (United States)

^k NORTHWESTERN UNIVERSITY   (United States)

^l LAKE ERIE COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

^m WRIGHT STATE UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ASYMPTOMATIC DISEASE; CHINA; COMMUNITY CONTACT; CONTROLLED STUDY; CORONAVIRUS DISEASE 2019; CORONAVIRUS INFECTION; COUGHING; DISEASE TRANSMISSION; DYSPNEA; EXPOSURE; FEMALE; FEVER; HEALTH CARE PERSONNEL; HEALTH CARE PERSONNEL CONTACT; HOSPITALIZATION; HUMAN; INCIDENCE; INCUBATION TIME; MALE; ONSET AGE; PATHOPHYSIOLOGY; PATIENT MONITORING; PERSON TO PERSON TRANSMISSION; PNEUMONIA; PRIORITY JOURNAL; SARS-RELATED CORONAVIRUS; SARS-RELATED CORONAVIRUS 2; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; SOCIAL BEHAVIOR; SYMPTOM; TRAVEL; UNITED STATES;

EID: 85081935465     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(20)30607-3     Document Type: Article

References (22)

1. WHO. Coronavirus disease (COVID-19) outbreak. 2020, World Health Organization https://www.who.int/emergencies/diseases/novel-coronavirus-2019. (Accessed 12 February 2020)
2. CDC. Locations with confirmed COVID-19 cases, global map. 2020, Centers for Disease Control and Prevention https://www.cdc.gov/coronavirus/2019-ncov/locations-confirmed-cases.html#map. (Accessed 12 February 2020)
3. Lu, R, Zhao, X, Li, J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 395 (2020), 565–574.
4. Chan, JF-W, Yuan, S, Kok, K-H, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 395 (2020), 514–523.
5. Phan, L, Nguyen, T, Luong, Q, et al. Importation and human-to-human transmission of a novel coronavirus in Vietnam. N Engl J Med 382 (2020), 872–874.
6. Li, Q, Guan, X, Wu, P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med, 2020 published online Jan 29. DOI:10.1056/NEJMoa2001316.
7. Chen, N, Zhou, M, Dong, X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395 (2020), 507–513.
8. WHO. Statement on the meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). Jan 23, 2020, World Health Organization https://www.who.int/news-room/detail/23-01-2020-statement-on-the-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov). (Accessed 12 February 2020)
9. Park, SW, Bolker, BM, Champredon, D, et al. Reconciling early-outbreak estimates of the basic reproductive number and its uncertainty: framework and applications to the novel coronavirus (2019-nCoV) outbreak. medRxiv, 2020 published online Feb 7. DOI: 10.1101/2020.01.30.20019877 (preprint).
10. CDC. Interim U.S. guidance for risk assessment and public health management of healthcare personnel with potential exposure in a healthcare setting to patients with 2019 novel coronavirus (2019-nCoV). 2020, Centers for Disease Control and Prevention https://www.cdc.gov/coronavirus/2019-ncov/hcp/guidance-risk-assesment-hcp.html. (Accessed 12 February 2020)
11. CDC. Interim US guidance for risk assessment and public health management of persons with potential 2019 novel coronavirus (2019-nCoV) exposure in travel-associated or community settings. 2020, Centers for Disease Control and Prevention https://www.cdc.gov/coronavirus/2019-ncov/php/risk-assessment.html. (Accessed 12 February 2020)
12. CDC. Appendix 2. Terminology. Infection control in healthcare personnel: infrastructure and routine practices for occupational infection prevention and control services (2019). 2019, Centers for Disease Control and Prevention https://www.cdc.gov/infectioncontrol/guidelines/healthcare-personnel/appendix/terminology.html. (Accessed 17 February 2020)
13. CDC. Health alert network: update and interim guidance on outbreak of 2019 novel coronavirus (2019-nCoV). 2020, Centers for Disease Control and Prevention https://emergency.cdc.gov/han/han00427.asp. (Accessed 12 February 2020)
14. CDC. Interim guidelines for collecting, handling, and testing clinical specimens from persons under investigation (PUIs) for 2019 novel coronavirus (2019-nCoV). 2020, Centers for Disease Control and Prevention https://www.cdc.gov/coronavirus/2019-ncov/lab/guidelines-clinical-specimens.html. (Accessed 12 February 2020)
15. CDC. Research use only real-time RT-PCR protocol for identification of 2019-nCoV. 2020, Centers for Disease Control and Prevention https://www.cdc.gov/coronavirus/2019-ncov/lab/rt-pcr-detection-instructions.html. (Accessed 12 February 2020)
16. CDC. Infection control basics. 2016, Centers for Disease Control and Prevention https://www.cdc.gov/infectioncontrol/basics/index.html. (Accessed 19 February 2020)
17. Chowell, G, Abdirizak, F, Lee, S, et al. Transmission characteristics of MERS and SARS in the healthcare setting: a comparative study. BMC Med, 13, 2015, 210.
18. Cowling, BJ, Park, M, Fang, VJ, Wu, P, Leung, GM, Wu, JT, Preliminary epidemiologic assessment of MERS-CoV outbreak in South Korea, May–June 2015. Euro Surveill, 20, 2015, 21175.
19. Shen, Z, Ning, F, Zhou, W, et al. Superspreading SARS events, Beijing, 2003. Emerg Infect Dis 10 (2004), 256–260.
20. Holshue, M, DeBolt, C, Lindquist, S, et al. First case of 2019 novel coronavirus in the United States. N Engl J Med 382 (2020), 929–936.
21. CDC. Interim guidance for preventing the spread of coronavirus disease 2019 (COVID-19) in homes and residential communities. 2020, Centers for Disease Control and Prevention https://www.cdc.gov/coronavirus/2019-ncov/hcp/guidance-prevent-spread.html. (Accessed 19 February 2020)
22. CDC. Evaluating and reporting persons under investigation (PUI). 2020, Centers for Disease Control and Prevention https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-criteria.html. (Accessed 19 February 2020)